Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News American Boarding MICBE

Healthcare Biotechnology
MicroLin Bio Inc is engaged in the healthcare sector. It is a therapeutic and diagnostic company focusing on microRNA and its role in oncology. MicroRNAs represent a class of diagnostics and therapeutics that are more effective in the diagnosis and treatment of cancer, with the potential for mitigating side effects in comparison with conventional small molecule drugs or biologics. The company's... see more

Recent & Breaking News (OTCPK:MICBE)

    Microlin Bio, Inc. to Present at 2016 Marcum MicroCap Conference

    GlobeNewswire May 31, 2016

    Microlin Bio, Inc. Announces Termination of Planned Marina Biotech Asset Purchase

    GlobeNewswire May 2, 2016

    Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech

    Marketwired March 15, 2016

    Microlin Bio Signs Exclusive License and Research Agreement With Université Laval to Develop microRNA-Based Treatments for Alzheimer's Disease

    GlobeNewswire February 10, 2016

    Microlin Bio, Inc. Announces Ticker Symbol Change to MICB

    GlobeNewswire January 14, 2016

    Microlin Bio, Inc. Announces Publication of Results From AntimiR-21 Lung Cancer Study in Molecular Pharmaceutics

    GlobeNewswire January 12, 2016

    Microlin Bio, Inc. Completes Reverse Merger and Becomes a Publicly Traded Company

    GlobeNewswire December 22, 2015